Skip to main content
Log in

Relationship between the Arg72Pro Polymorphism of p53 and outcome for patients with traumatic brain injury

  • Original
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

Objective

To determine the relationship between the Arg72Pro polymorphism of p53 and the outcome after traumatic brain injury (TBI) in humans.

Design and setting

A prospective study was carried out in a ten-bed surgical intensive care unit (SICU) of a university hospital.

Patients

The study included 90 caucasian patients who had experienced a severe TBI within the previous 24 h. The exclusion criterion was a previous deficit in the central nervous system.

Measurements and results

The main recorded outcomes were values on the Glasgow Outcome Scale (GOS) at discharge from the SICU (GOS-0) and 6 months later (GOS-6). A blood sample was taken from each patient and all samples were analyzed by an allele-specific polymerase chain reaction for detection of Arg72Pro polymorphism of p53. These polymorphisms were tested for their association with values of GOS-0 and GOS-6. A two-tailed value of p<0.05 was considered statistically significant. The frequency of the argine/argine (Arg/Arg) genotype was greater among the patients who had a bad outcome at GOS-0 (69 vs 31% in the bad-outcome group; p=0.029). A multiple logistic regression analysis showed that patients with the Arg/Arg variation had a 2.9-fold greater risk of having a bad outcome at discharge from the SICU (95% confidence interval, 1.05–8.31; p=0.039 ). There was no similar relationship with respect to GOS-6.

Conclusion

The Arg/Arg genotype of the Arg72Pro polymorphism in p53 is associated with increased likelihood of a bad outcome at discharge from the SICU.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Ng I, Yeo TT, Tang WY, Soong R, Ng PY, Smith DR (2000) Apoptosis occurs after cerebral contusions in humans. Neurosurgery 46:949–955

    CAS  PubMed  Google Scholar 

  2. Smith DH, Chen XH, Pierce JE, Wolf JA, Trojanowski JQ, Graham DI, McIntosh TK (1997) Progressive atrophy and neuron death for one year following brain trauma in the rat. J Neurotrauma 14:715–727

    CAS  PubMed  Google Scholar 

  3. Clark RSB, Kochanek PM, Chen M, Watkins SC, Marion DW, Chen J, Hamilton RL, Loeffert JE, Graham SH (2000) Increases in Bcl-2 and cleavage of caspase-1 and caspases-3 in human brain after head injury FASEB J 13:813–821

    Google Scholar 

  4. Evan G, Littlewood T (1998) A matter of life and cell death. Science 281:1317–1322

    CAS  PubMed  Google Scholar 

  5. Fisher DE(2001) The p53 tumor supressor: critical regulator of life and death in cancer. Apoptosis 6:7–15

    CAS  PubMed  Google Scholar 

  6. Lu J, Moochhala S, Kaur C, Ling E (2000) Changes in apoptosis-related protein (p53,Bax,Bcl-2 and Fos) expression with DNA fragmentation in the central nervous system in rats after closed head injury. Neurosci Lett 290:89–92

    CAS  PubMed  Google Scholar 

  7. Chopp M, Li Y, Jiang N (1999) Increase in apoptosis and concomitant reduction of ischemic lesion volume and evidence for synaptogenesis after transient focal cerebral ischemia in rat treated with staurosporine. Brain Res 828:197–201

    CAS  PubMed  Google Scholar 

  8. Sakhi S, Bruce A, Sun N, Tocco G, Baudry M, Schreiber SS (1994) p53 induction is associated with neuronal damage in the CNS. Proc Natl Acad Sci USA 91:7525–7529

    CAS  PubMed  Google Scholar 

  9. Hughes PE, Alexi T, Yoshida T, Schreiber SS, Knusel B (1996) Excitotoxic lesion of rat brain with quinolinic acid induces expression of p53 messenger RNA and protein and p53-inducible genes Bax and Gadd-45 in brain areas showing DNA fragmentation. Neuroscience 74:1143–1160

    CAS  PubMed  Google Scholar 

  10. Kaya SS, Mahmood A, Li Y, Yavuz E, Goksel M, Chopp M (1999) Apoptosis and expression of p53 response proteins and cyclin D1 after cortical impact in rat brain. Brain Res 818:23–33

    CAS  PubMed  Google Scholar 

  11. Napieralski JA, Raghupathi R, McIntosh TK (1999) The tumor-suppressor gene, p53, is induced in injured brain regions following experimental traumatic brain injury. Mol Brain Res 71:78–86

    CAS  PubMed  Google Scholar 

  12. Crumrine RC, Thomas AL, Morgan PF (1994) Attenuation of p53 expression protects against focal ischemic damage in transgenic mice. J Cereb Blood Flow Metab 14:887–891

    CAS  PubMed  Google Scholar 

  13. Morrisson RS, Wenzel HJ, Kinoshita Y, Robbins CA, Donehower LA, Schwartzkroin PA (1996) Loss of the p53 tumor supressor gene protects neurons from kainate-induced cell death. J Neurosci 16:1337–1345

    PubMed  Google Scholar 

  14. Harris N, Brill E, Shohat O, Prokocimer M, Wolf D, Arai N, Rotter V (1986) Molecular basis for heterogeneity of the human p53 protein. Mol Cell Biol 6:4650–4656

    CAS  PubMed  Google Scholar 

  15. Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G (1999) Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 19:1092–1100

    CAS  PubMed  Google Scholar 

  16. Ara S, Lee PS, Hansen MF, Saya H (1990) Codon 72 polymorphism of the TP53 gene. Nucleic Acids Res 18:4961

    CAS  Google Scholar 

  17. Dumont P, Leu JI, Della Pietra AC III, George DL, Murphy M (2003) The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33:357–365

    CAS  PubMed  Google Scholar 

  18. Martínez-Lucas P, Moreno-Cuesta J, Picazo-Martínez M, Cuartero del Pozo A, García-Olmo DC, Guardiola-Salmerón M, García-Olmo D (2004) Role of codon 72 polymorphic variants of p53 in outcome after traumatic brain injury. Intensive Care Med Suppl 30:S138

    Google Scholar 

  19. Bullock R, Chestnut RM, Clifton G, Ghajar J, Marion DW, Narayan RK, Newell DW, Pitts LH, Rosner MJ, Wilberger JW (1996) Guidelines for the management of severe head injury. Brain Trauma Foundation. Eur J Emerg Med 3:109–127

    CAS  PubMed  Google Scholar 

  20. Jennet B, Snoek J, Bond MR, Brooks N (1981) Disability after severe head injury: observations on the use of the Glasgow Outcome Scale. J Neurol Neurosurg Psychiatry 44:285–293

    PubMed  Google Scholar 

  21. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, Breuer J, Leigh IM, Matlashewski G, Banks L (1998) Role of p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 393:229–234

    CAS  PubMed  Google Scholar 

  22. Peters DL, Barber RC, Flood EM, Garner HR, O’Keefe GE (2003) Methodologic quality and genotyping reproducibility in studies of tumor necrosis factor-308 G-A single nucleotide polymorphism and bacterial sepsis: implications for studies of complex traits. Crit Care Med 31:1691–1696

    CAS  PubMed  Google Scholar 

  23. Mira JP, Cariou A, Grall F, Delclaux C, Losser MR, Heshmati F, Cheval C, Monchi M, Teboul JL, Riche F, Leleu G, Arbibe L, Mignon A, Delpech M, Dhainaut JF (1999) Association of TNF2, a TNF-α promoter polymorphism, with septic shock susceptibility and mortality. J Am Med Assoc 282:561–568

    CAS  Google Scholar 

  24. Raghupathi R, Graham DI, McIntosh TK (2000) Apoptosis after traumatic brain injury. J Neurotrauma 17:927–938

    CAS  PubMed  Google Scholar 

  25. Nathoo N, Narotam PK, Agrawal DK, Connolly CA, van Dellen JR, Barnet GH, Chetty R (2004) Influence of apoptosis on neurological outcome following traumatic cerebral contusion. J Neurosurg 101:233–240

    PubMed  Google Scholar 

  26. Scheneider-Stock R, Mawrin C, Motsch C, Boltze C, Peters B, Hartig R, Buhtz P, Giers A, Rohrbeck A, Freigang B, Roessner A (2004) Retention of the arginine allele in codon 72 of the p53 gene correlates with poor apoptosis in head and neck cancer. Am J Pathol 164:1233–1241

    PubMed  Google Scholar 

  27. Granja F, Morari J, Morari EC, Correa LA, Assumpcao LV, Ward LS (2004) Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer. Cancer Lett 210:151–157

    CAS  PubMed  Google Scholar 

  28. Sullivan A, Syed N, Gasco M, Bergamaschi D, Trigiante G, Attard M, Hiller L, Farrell PJ, Smith P, Lu X, Crook T (2004) Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo. Oncogene 23:3328–3337

    CAS  PubMed  Google Scholar 

  29. Pim D, Banks L (2004) p53 polymorphic variants at codon 72 exert different effects on cell cycle progression. Int J Cancer 108:196–199

    CAS  PubMed  Google Scholar 

  30. Bonafe M, Salvioli S, Barbi C, Trapassi C, Tocco F, Storci G, Invidia L, Vannini I, Rossi M, Marzi E, Mishto M, Capri M, Olivieri F, Antonicelli R, Memo M, Uberti D, Nacmias B, Sorbi S, Monti D, Franceschi C (2004) The different apoptotic potential of the p53 codon 72 alleles increases with age and modulates in vivo ischemia-induced cell death. Cell Death Differ 11:962–973

    CAS  PubMed  Google Scholar 

  31. Hartley C, Cozens A, Mendelow AD, Stevenson JC (1995) The APACHE II scoring system in neurosurgical patients: a comparison with simple Glasgow coma scoring. Br J Neurosurg 9:179–187

    CAS  PubMed  Google Scholar 

  32. Lai YC, Chen FG, Goh MH, Koh KF (1998) Predictors of long-term outcome in severe head injury. Ann Acad Med Singapore 27:326–331

    CAS  PubMed  Google Scholar 

  33. Cooke RS, McNicholl BP, Byrnes DP (1995) Use of the Injury Severity Score in head injury. Injury 26:399–400

    CAS  PubMed  Google Scholar 

  34. Cho DY, Wang YC (1997) Comparison of the APACHE III, APACHE II and Glasgow Coma Scale in acute head injury for prediction of mortality and functional outcome. Intensive Care Med 23:77–84

    CAS  PubMed  Google Scholar 

  35. Bullock MR, Merchant RE, Choi SC, Gilman CB, Kreutzer JS, Marmarou A, Teasdale GM (2002) Outcome measures for clinical trials in neurotrauma. Neurosurg Focus 13:1–11

    Google Scholar 

  36. Choi SC, Barnes TY, Bullock R, Germanson TA, Marmarou A, Young HF (1994) Temporal profile of outcomes in severe head injury. J Neurosurg 81:169–173

    CAS  PubMed  Google Scholar 

  37. Brown PJ, Fleiszer D (1989) The value of the Glasgow Coma Scale and Injury Severity Score: predicting outcome in multiple trauma patients with head injury. J Trauma 29:746–748

    PubMed  Google Scholar 

  38. Woischneck D, Firsching R (1998) Efficiency of the Glasgow Outcome Scale (GOS)-Score for the long term follow-up after severe brain injuries. Acta Neurochir Suppl 71:138–141

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements. This study was supported, in part, by a grant from the Research Committee of the General University Hospital of Albacete (Spain). The authors thank Ms. M.G. Picazo for her invaluable technical assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jerónimo Moreno-Cuesta.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Martínez-Lucas, P., Moreno-Cuesta, J., García-Olmo, D.C. et al. Relationship between the Arg72Pro Polymorphism of p53 and outcome for patients with traumatic brain injury. Intensive Care Med 31, 1168–1173 (2005). https://doi.org/10.1007/s00134-005-2715-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-005-2715-0

Keywords

Navigation